von Willebrand factor

Ligand id: 6755

Name: von Willebrand factor

Species: Human

No information available.
Summary of Clinical Use
A recombinant version of the protein (Vonvendi®) has been approved by the US FDA as the first recombinant vWF product licensed to be used on-demand for von Willebrand disease (VWD) patients suffering bleeding episodes. This approval replaces the need to use vWF concentrate, which was purified from human plasma.